| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.119.661.274 $ | +36.759.784 $ | +35,3 % | 9 | 1.024.917.654 $ | +262.704.255 $ | +35,8 % | 7 | 938.537.721 $ | +250.265.679 $ | +39,6 % | 9 | ||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 155.396.870 $ | -63.591.851 $ | -29,0 % | 1 | 218.988.721 $ | +105.743.291 $ | +93,4 % | 1 | 113.245.430 $ | +52.268.871 $ | +85,7 % | 1 |
| Syndax Pharmaceuticals Inc | SNDX | → 0 | Neutral | 188.070.402 $ | +18.919.753 $ | +11,2 % | 1 | 169.150.649 $ | +38.070.449 $ | +29,0 % | 1 | 131.080.200 $ | +51.290.400 $ | +64,3 % | 1 |
| Celldex Therapeutics, Inc. | CLDX | → 0 | Schwach | 185.262.785 $ | +23.846.016 $ | +14,8 % | 1 | 161.416.769 $ | +3.590.910 $ | +2,3 % | 1 | 157.825.859 $ | +33.676.024 $ | +27,1 % | 1 |
| Vera Therapeutics, Inc. | VERA | → 0 | Neutral | 136.710.552 $ | -37.139.151 $ | -21,4 % | 1 | 173.849.703 $ | +56.801.835 $ | +48,5 % | 1 | 117.047.868 $ | +36.310.410 $ | +45,0 % | 1 |
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 169.816.887 $ | +34.980.350 $ | +25,9 % | 1 | 134.836.537 $ | +24.197.937 $ | +21,9 % | 1 | 110.638.600 $ | +10.781.274 $ | +10,8 % | 1 |
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Schwach | 95.554.665 $ | +33.652.246 $ | +54,4 % | 1 | ||||||||
| Beam Therapeutics Inc. | BEAM | → 0 | Neutral | 87.746.469 $ | -5.869.903 $ | -6,3 % | 1 | 93.616.372 $ | +32.513.079 $ | +53,2 % | 1 | 61.103.293 $ | +19.979.118 $ | +48,6 % | 1 |
| CG Oncology, Inc. | CGON | → 0 | Neutral | 80.769.657 $ | +16.870.315 $ | +26,4 % | 1 | ||||||||
| BIOCRYST PHARMACEUTICALS INC | BCRX | → 0 | Stark | 54.081.168 $ | -18.977.735 $ | -26,0 % | 1 | 73.058.903 $ | +1.786.754 $ | +2,5 % | 1 | 71.272.149 $ | -4.562.979 $ | -6,0 % | 1 |
| Travere Therapeutics, Inc. | TVTX | → 0 | Schwach | 72.014.604 $ | +52.226.256 $ | +263,9 % | 1 | ||||||||
| CytomX Therapeutics, Inc. | CTMX | → 0 | Schwach | 70.561.537 $ | +32.366.049 $ | +84,7 % | 1 | ||||||||
| 1.119.661.274 $ | +36.759.784 $ | +35,3 % | 9 | 1.024.917.654 $ | +262.704.255 $ | +35,8 % | 7 | 938.537.721 $ | +250.265.679 $ | +39,6 % | 9 | ||||